{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:56:52Z","timestamp":1761742612470},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.cccn.2005.07.011","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T11:31:28Z","timestamp":1124451088000},"page":"251-255","source":"Crossref","is-referenced-by-count":36,"title":["Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) study"],"prefix":"10.1016","volume":"364","author":[{"given":"Stefan","family":"Pilz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"Maerz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Weihrauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Sargsyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Almer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard O.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard R.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Mangge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2005.07.011_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cccn.2005.07.011_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cccn.2005.07.011_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cccn.2005.07.011_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.ijo.0802983","article-title":"Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women","volume":"29","author":"Kopp","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cccn.2005.07.011_bib5","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1210\/jc.2002-021583","article-title":"Novel interactions of adiponectin with the endocrine system and inflammatory parameters","volume":"88","author":"Fernandez-Real","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cccn.2005.07.011_bib6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2337\/diacare.26.6.1745","article-title":"Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian","volume":"26","author":"Krakoff","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cccn.2005.07.011_bib7","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.86.5.1930","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsuliemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cccn.2005.07.011_bib8","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jc.87.6.2764","article-title":"Decreased plasma adiponectin concentrations in women with dyslipidemia","volume":"87","author":"Matsubara","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cccn.2005.07.011_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/heart.89.6.663","article-title":"Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease","volume":"89","author":"Miyazaki","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.cccn.2005.07.011_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.02.020","article-title":"Adiponectin and atherosclerotic disease","volume":"344","author":"Shimada","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cccn.2005.07.011_bib11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2005.07.011_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumuda","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cccn.2005.07.011_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2003.011114","article-title":"Implications of plasma concentrations of adiponectin in patients with coronary artery disease","volume":"90","author":"Nakamura","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cccn.2005.07.011_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/heart.89.6.667","article-title":"The variation of plasma concentrations of a novel adipocyte derived protein, adiponectin, in patients with acute myocardial infarction","volume":"89","author":"Kojima","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.cccn.2005.07.011_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cccn.2005.07.011_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1536\/jhj.45.921","article-title":"Diabetes mellitus has an additional effect on coronary artery disease","volume":"45","author":"Chan","year":"2004","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.cccn.2005.07.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14622416.2.1.S1","article-title":"Rationale and design of the LURIC study: a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cccn.2005.07.011_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2005.07.011_bib19","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2005.07.011_bib20","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/01.CIR.0000018622.84402.FF","article-title":"Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor induced common postreceptor signal in vascular smooth muscle cell","volume":"105","author":"Arita","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2005.07.011_bib21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-[kappa]B signaling through cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2005.07.011_bib22","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cccn.2005.07.011_bib23","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2005.07.011_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2007-978586","article-title":"An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls","volume":"32","author":"Okamoto","year":"2000","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cccn.2005.07.011_bib25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.cccn.2005.07.011_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-004-1597-y","article-title":"The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complication study","volume":"48","author":"Costacou","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cccn.2005.07.011_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000153090.21990.8c","article-title":"Adiponectin and coronary heart disease: the strong heart study","volume":"25","author":"Lindsay","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cccn.2005.07.011_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2005-0167","article-title":"Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin","author":"Pilz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cccn.2005.07.011_bib29","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPAR\u03b3 ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cccn.2005.07.011_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator-activated receptor-\u03b3 agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cccn.2005.07.011_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-005-0667-z","article-title":"The adiponectin SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age\u226450 years)","author":"Filippi","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.cccn.2005.07.011_bib32","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of adipocyte secreted hormone Acrp30\/adiponectin. Implications for metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cccn.2005.07.011_bib33","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105004596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105004596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:21:54Z","timestamp":1548253314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105004596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0009898105004596"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2005.07.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}